In a new SEC filing on August 11, it was revealed that Emerson, EVP at IDEXX Laboratories IDXX, executed a significant exercise of company stock options. What Happened: A Form 4 filing from the U.S.

In a new SEC filing on February 11, it was revealed that Fennell, Executive Vice President at IDEXX Laboratories (NASDAQ:IDXX), executed a significant exercise of company stock options. What Happened: ...

A substantial insider activity was disclosed on February 12, as Erickson, Executive Vice President at IDEXX Laboratories (NASDAQ:IDXX), reported the exercise of a large sell of company stock options.

Idexx Laboratories ((IDXX)) has held its Q3 earnings call. Read on for the main highlights of the call. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, ...

IDEXX Laboratories (NASDAQ:IDXX) traded higher on Thursday after the animal health company reported better-than-expected financials for Q1 2025 and lifted its full-year outlook, citing forex gains.

Feb 3 (Reuters) - IDEXX Laboratories (IDXX.O), opens new tab beat Wall Street estimates for fourth-quarter revenue and profit on Monday, helped by strong demand for its veterinary diagnostic services ...

Achieves first quarter revenue growth of 4% as reported and 5% organic, supported by CAG Diagnostics recurring revenue growth of 3% as reported and 4.5% organic. Organic revenue growth supported by ...

IDEXX Laboratories’ recent earnings call reflected a generally positive sentiment, highlighting the company’s strong financial performance and increased full-year guidance. The company reported ...